Most health-conscious adults can recite their cholesterol number, their blood pressure reading, and roughly where their blood sugar sits. Ask the same person about their gut microbiome, the trillions of bacteria living in their digestive tract, and the conversation tends to stall. Not because it matters less, but because almost nobody has ever had it measured.
That gap is getting harder to justify. A growing body of research ties the composition and diversity of gut bacteria to digestion, immune function, inflammation, and metabolic health, the same systems behind the conditions preventive health checkups exist to catch early. Yet gut health remains the one major biological system most routine checkups skip entirely.
Why the Gut Microbiome Matters More Than Most People Realise
The gut hosts an estimated hundreds of trillions of microorganisms, collectively outnumbering the body’s own cells. These bacteria do considerably more than help digest food:
Join The European Business Briefing
New subscribers this quarter are entered into a draw to win a Rolex Submariner. Join 40,000+ founders, investors and executives who read EBM every day.
Subscribe- They manufacture certain vitamins the body cannot produce on its own.
- They train and regulate the immune system.
- They influence how the body processes and stores fat.
- They communicate with the brain via the gut-brain axis, a bidirectional relationship operating through neural, immune, and metabolic pathways, and increasingly linked to mood and cognitive function.
When this ecosystem is diverse and balanced, it tends to support stable digestion, a well-regulated immune response, and lower systemic inflammation. When it is depleted or imbalanced, a state researchers call dysbiosis, it has been associated with digestive symptoms, raised inflammatory markers, and more difficulty maintaining metabolic health. Researchers are still working out how much of that relationship is cause and how much is consequence.
The honest caveat is worth stating plainly: microbiome science is still maturing. Causation is harder to prove than correlation in this field, and no serious researcher claims the gut microbiome alone explains someone’s health. But the direction of the evidence is consistent enough that treating it as background noise, while routinely testing cholesterol and blood sugar, is an increasingly difficult position to defend.
Why It Gets Overlooked
Part of the reason gut health slips through is that its symptoms are easy to dismiss or attribute elsewhere:
- Bloating, fatigue, irregular digestion, and low-grade inflammation are common enough that people normalise them rather than investigate them.
- Unlike a cholesterol test, where the number itself prompts a conversation, gut symptoms tend to get managed one at a time, an antacid here, a dietary tweak there.
- Nobody traces these symptoms back to a single underlying system worth assessing properly, because that system has never been visible to begin with.
Why Testing It Is the Missing Piece
You cannot meaningfully improve what you have never measured. That holds for blood pressure, and it holds just as firmly for gut health, except that gut health has historically been far harder to measure in any useful way. Stool-based sequencing technology has changed that, making it possible to analyse the actual bacterial composition of someone’s gut rather than infer it from symptoms.
This is where the quality of the test, and what happens with the result, starts to matter enormously. Everlab, an Australian preventive health provider, illustrates where this is heading. A gut microbiome test Australia arranged through Everlab does not arrive as a bare species list emailed back with no explanation. A doctor reviews the result against the person’s wider health profile first, so reduced microbial diversity or a specific imbalance is treated as one data point among several, rather than a standalone verdict the person is left to Google.
That distinction, a result a clinician actually interprets versus a report a consumer is left to self-diagnose from, is arguably the single biggest differentiator in this space right now:
- Raw sequencing data without clinical context can be more confusing than clarifying.
- It is a meaningful reason gut microbiome testing has been slower to earn mainstream clinical trust than more established blood panels.
- Dysbiosis itself is implicated across multiple organ systems, not just digestion, including gut-lung and gut-liver communication pathways.
It is also why gut microbiome testing works best as part of a broader health picture rather than a standalone novelty. A result showing low microbial diversity means something different for someone already managing digestive symptoms than it does for someone with no symptoms at all, and it means something different again when read alongside markers like inflammation or metabolic health rather than in isolation. That is precisely the gap a doctor-reviewed approach is built to close, context a mail-in consumer kit, however sophisticated its lab work, generally cannot provide on its own.
What This Signals for Preventive Health More Broadly
The trajectory here mirrors what happened with other biomarkers decades ago. Cholesterol testing was not always routine. Neither was HbA1c for blood sugar. Both became standard once the evidence matured and the testing became accessible enough for mainstream clinical use, not just specialist settings.
Gut microbiome testing appears to be following a similar arc, moving from niche research interest to something a genuine preventive health provider offers as part of a standard assessment, with proper clinical interpretation rather than a novelty report. For a system of care built on catching problems before they become serious, that is not a trend to watch from the sidelines. It is a gap worth closing.
